미국 · 보도자료 · VOGX · 2026-10-09 12:00
보젠스, 리차드 고먼 이사를 최고상업책임자(CCO)로 선임
Vogenx, Inc. (Nasdaq:VOGX), a clinical-stage developer of novel therapeutics for the treatment of serious metabolic and gastrointestinal diseases, today announced that Richard "Rich" Gorman will join the Vogenx management team as Chief Commercial Officer, effective October 12, 2026. Concurrent with his joining the management team, Mr. Gorman, who has served as an independent member of the Vogenx B
